Delivery Order SPE2DB24D2100-SPE2DB25FBEMS
Award Date 6/3/25
Potential Completion Date 6/25/25
Potential Value $22K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $21,827.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of TIBSOVO 250 mg on August 7, 2025, with completion scheduled for August 28, 2025. This non-set-aside award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of TIBSOVO 250 mg, a pharmaceutical product used in oncology treatment. This firm fixed-price delivery order, valued at $21,827.40, was competitively awarded without set-aside provisions and is scheduled for completion by May 14, 2025. The order was placed on April 23, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $21,827.40 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Tibsovo 250 mg tablets (60-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion deadline of September 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is performing the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $21,827.41 to AmerisourceBergen Drug Corp for TIBSOVO 250 mg tablets (60-count units) on November 6, 2025, with completion scheduled for December 1, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a $21.8K delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Tibsovo (ivosidenib) 250 mg tablets in a quantity of 60 units. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The contract is set to be completed by December 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on November 4, 2025, for TIBSOVO 250 mg tablets (60-count supply) with a firm fixed price ceiling value of $21,827.41. The contract is scheduled for completion by November 26, 2025. This is a competitively awarded, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 28, 2025, by the Defense Logistics Agency to supply 60 tablets of Tibsovo 250 mg, a prescription medication used in oncology treatment. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $43,654.80 and is scheduled for completion by October 20, 2025. The contract contains no set-aside designation and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,827.40, is for the supply of TIBSOVO 250 MG TABLET 60S, a specialty pharmaceutical product. The contract has a period of performance through March 14, 2025, and is a firm fixed-price type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TIBSOVO 250 MG TABLET 60S, a prescription medication, with a total ceiling value of $21,827.40 and a period of performance through July 22, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,827.40, is for the supply of TIBSOVO 250 MG Tablets and has a period of performance ending on February 14, 2025. The contract does not have a set-aside designation, indicating that it was open to competition. Amerisourcebergen Drug Corp holds a significant Indefinite...